How can we improve the provision of high quality care?     Join the Quality & Safety Community

Médecins Sans Frontières/Doctors Without Borders (MSF) is holding its annual Scientific Day conference tomorrow at the Royal Society of Medicine in London. Many experts will present the research they carry out at MSF programmes around the world. The day is packed – 5 sessions, 20+ speakers, all available live on the web via video streaming (http://www.msf.org.uk/msf-scientific-day). Hans Rosling, co-founder of Gapminder (http://www.gapminder.org/) and MSF in Sweden and TED talks alumnus (http://www.ted.com/speakers/hans_rosling.html) will be giving the keynote address on the synergy and conflict between research and advocacy at 2PM BST/9AM EDT.
A few hours later, at 4PM BST/11AM EDT, I will be talking to Hans about his work and how it can help shape advocacy for global health (stay tuned on our community and social media - @ghdonline and https://www.facebook.com/globalhealthdelivery for details).

Have you used Gapminder or other data visualization tools? These can be powerful tools for advocacy but how can we best utilize them? Please let me know if you have questions for Hans. I look forward to this discussion.

Thank you, Gene

--
Gene Bukhman, MD, PhD
Director, Program in Global Non-Communicable Disease and Social Change
Assistant Professor
Harvard Medical School and Partners In Health

 
Sophie Beauvais
Replied at 1:25 PM, 10 May 2013

Dear All,

Due to a technical glitch we were unfortunately unable to record the conversation between Hans and Gene this morning. This exchange nevertheless reminded us that the global health and development community is much divided on the question of non-communicable diseases in populations living in extreme poverty. Some questions I take away from this: Can/should NCDs of extreme poverty be integrated into current HIV, TB, and Malaria programs? What is the role of health systems strengthening in alleviating extreme poverty and addressing NCDs? It would be great to read your reactions. Thank you.

  Sign in to reply